drugset / Trial / NCT05461456
Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%
NaSingle-groupOpen-labelTreatment
Summary
The investigational lotion is envisaged as an short- and long term "Ease \& Prevent" monotherapy for adults and children with mild to moderate eczema. With itch representing the most burdensome symptom in eczema, the main objectives with the lotion is fast and efficient itch relief, high tolerability, and high short- and long term safety. This phase 1 study aims to monitor skin tolerability, and how much of the active compound that is absorbed to the bloodstream.
Timeline
- Start
- 2022-04-01
- Primary completion
- 2022-10-16
- Completion
- 2022-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fexofenadine | Unknown | 1 % | Topical |
| Subject | Fexofenadine | Unknown | 11 g | Topical |